Adopting a healthier lifestyle is more effective than using the anti-diabetes drug metformin, with the benefits persisting ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Other trials are testing whether the drug can treat sleep apnoea or type 2 diabetes. The growing number of new GLP-1 drugs target multiple pathways at the same time so will result in more-tailored ...

A promising new insulin pill is just several months away from being trialled by people living with diabetes in ...